کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
6223657 | 1607469 | 2013 | 6 صفحه PDF | دانلود رایگان |
ObjectiveTo compare indices of insulin secretion, insulin sensitivity (IS), and oral disposition index (oDI) during the liquid mixed-meal test in obese youth with clinically diagnosed type 2 diabetes mellitus (T2DM) and negative autoantibodies (Abâ) versus those with T2DM and positive autoantibodies (Ab+) to examine whether differences in β-cell function can be detected between the 2 groups.Study designTwenty-seven youth with Abâ and 15 youth with Ab+ clinically diagnosed T2DM underwent a mixed-meal test (Boost; 55% carbohydrate, 25% protein, and 20% fat). Fasting and mixed-meal-derived insulin and C-peptide indices of IS, secretion (30-minute insulinogenic [ÎI30/ÎG30] and C-peptide [ÎC30/ÎG30]), and oDI were calculated.ResultsIndices of insulin secretion were â¼40%-50% lower in patients with Ab+ T2DM compared with those with Abâ T2DM. After controlling for body mass index, ÎI30/ÎG30, ÎC30/ÎG30, C-peptide area under the curve (AUC)/glucose AUC, and insulin AUC/glucose AUC were significantly (P < .05) lower in the Ab+ group compared with the Abâ group. Sensitivity indices were significantly higher in the Ab+ group. The oDI, 1/fasting insulin Ã ÎI30/ÎG30 (0.04 ± 0.02 vs 0.12 ± 0.02 mg/dLâ1; P = .005), and 1/fasting C-peptide Ã ÎC30/ÎG30 (0.02 ± 0.009 vs 0.05 ± 0.006 mg/dLâ1; P = .018) were lower in the Ab+ group. Receiver operating characteristic curve analyses revealed that fasting C-peptide <3.2 ng/mL had 87% sensitivity and 74% specificity and ÎC30/ÎG30 <0.075 ng/mL per mg/dL had 93% sensitivity and 80% specificity for identifying youth with Ab+ T2DM.ConclusionDuring a liquid mixed-meal test, indices of β-cell function were lower and IS was higher in patients with Ab+ T2DM versus those with Abâ T2DM, with high sensitivity and specificity for fasting and stimulated C-peptide as markers of Ab+ status. Indices of insulin secretion during this standardized mixed-meal test could be used to assess β-cell function in therapeutic trials of β-cell restoration in youth with T2DM.
Journal: The Journal of Pediatrics - Volume 162, Issue 5, May 2013, Pages 924-929